How Is Zoetis’ Stock Performance Compared to Other Pet Care Stocks?
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 04 2025
0mins
Source: NASDAQ.COM
Company Overview and Stock Performance: Zoetis Inc., a leading producer of animal health products, has seen its stock decline 16.5% from its 52-week high, with a notable drop of 8.9% over the past year despite better-than-expected financial results for Q4 and fiscal 2024.
Future Outlook and Analyst Sentiment: Although Zoetis expects stagnant revenue growth for fiscal 2025, analysts maintain a "Strong Buy" rating on the stock, with a price target suggesting a potential 25.4% increase from current levels.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ZTS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ZTS
Wall Street analysts forecast ZTS stock price to rise
12 Analyst Rating
7 Buy
5 Hold
0 Sell
Moderate Buy
Current: 80.070
Low
130.00
Averages
154.20
High
200.00
Current: 80.070
Low
130.00
Averages
154.20
High
200.00
About ZTS
Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including vaccines, anti-infectives, parasiticides, dermatology, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The Company is engaged in commercializing products across eight species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Zoetis Under Investigation for Securities Fraud Claims
- Financial Performance Decline: Zoetis reported a net income of $601 million for Q1 2026, flat year-over-year, indicating the company is under pressure in a competitive market, which may affect future investor confidence.
- Guidance Downgrade: The company lowered its full-year 2026 earnings guidance to between $6.85 and $7.00 per share, down from $7.00 to $7.10, reflecting concerns over weakening market demand that could diminish shareholder confidence in the company's future performance.
- Significant Stock Drop: Following the earnings release on May 7, 2026, Zoetis's stock price plummeted by $23.91, or 21.5%, closing at $87.31, demonstrating a strong market reaction to the company's financial health, which may impact its ability to raise capital.
- Legal Investigation Initiated: Pomerantz LLP is investigating whether Zoetis and its executives engaged in securities fraud or other unlawful business practices, which could expose the company to legal risks and further impact its market reputation and shareholder value.
See More
Zoetis to Participate in Investor Conferences
- Investor Conference Schedule: Zoetis will participate in the Stifel 2026 Jaws & Paws Conference on May 28, 2026, at 3:00 p.m. ET, showcasing its latest advancements in animal health, which is expected to attract significant investor interest.
- Second Conference: Additionally, Zoetis will attend the William Blair 46th Annual Growth Stock Conference on June 2, 2026, at 1:20 p.m. CT, further enhancing the company's visibility and credibility among investors.
- Live Webcast Access: Interested investors can access live audio webcasts of the presentations by visiting the Zoetis investor website, which enhances interaction and transparency between the company and its investors.
- Company Background: Zoetis is the world's leading animal health company with nearly 75 years of history, dedicated to advancing animal care through innovation and scientific research, supporting veterinarians and livestock producers in over 100 countries.
See More
Zoetis Declares Quarterly Dividend of $0.53
- Quarterly Dividend Announcement: Zoetis has declared a quarterly dividend of $0.53 per share, consistent with previous distributions, indicating the company's stability amidst current market challenges despite declining sales.
- Dividend Yield: The forward yield of 2.66% provides investors with a relatively stable return, although the overall market sentiment regarding Zoetis's outlook remains cautious due to recent performance issues.
- Payment Schedule: The dividend will be payable on September 1, with a record date of July 20 and an ex-dividend date also set for July 20, ensuring shareholders receive their earnings promptly.
- Revenue Growth Forecast: Zoetis projects revenue growth of 2%-5% for 2026, reflecting a softening demand for U.S. companion animals, as the company continues to navigate market fluctuations and adapt its strategies accordingly.
See More
Michael Burry Doubles Down on Undervalued Stocks Amid AI Bubble Warning
- Market Bubble Warning: In his latest Substack post, Michael Burry cautions that the current AI boom resembles the final stages of the 1999 dot-com bubble, urging investors to exercise caution around momentum-driven trades and suggesting nearly complete reductions in positions for any stocks experiencing parabolic rises.
- Increased Holdings in Undervalued Stocks: Burry has added to his position in Latin American e-commerce giant MercadoLibre at around $1,500, describing it as a 'clean long-term winner' trading at a discount due to its international exposure, indicating a strategic focus on global markets.
- Diversified Investment Portfolio: In addition to MercadoLibre, Burry has boosted stakes in software maker Adobe, payments company PayPal, and animal health firm Zoetis, while establishing a full-sized position in athletic apparel retailer Lululemon, reflecting his confidence in traditional industries amidst the AI hype.
- Concentration of Risk: Burry highlights that 87% of venture capital funding is now directed toward AI-related companies, with nearly half of investment-grade bond issuance linked to AI, suggesting a concentration of capital that mirrors the dynamics preceding the 1999 internet bubble, indicating potential future risks.
See More
Earnings Season Volatility Hits US Stocks
- Strong Earnings Season: As the earnings season progresses, the S&P 500 reached an intraday record high of 7,501.24 on Thursday, reflecting strong investor confidence in corporate earnings, although it pulled back on Friday due to declines in tech stocks.
- Cisco's Stock Surge: Cisco shares soared 22% in one week following better-than-expected fiscal Q3 results, with a relative strength index (RSI) of 90 indicating the stock is in overbought territory, suggesting a potential short-term pullback risk.
- Zoetis Decline: Zoetis topped the oversold list with a 10% drop in the past week and an RSI of 14.4, as its Q1 earnings fell short of expectations and it lowered full-year EPS and revenue guidance, indicating pet owners are cutting back on vet visits due to price pressures.
- Market Sentiment Fluctuations: Despite strong performances from stocks like Cisco, the overall market experienced volatility due to disappointment over the U.S.-China summit outcomes, prompting investors to watch for potential rebounds in overbought and oversold stocks.
See More
Semiconductor Stocks Surge, Defensive Stocks Under Pressure
- Semiconductor Stocks Shine: Companies like Intel, Micron, and Seagate have surged over 40% in 2026, significantly exceeding their 200-day moving averages, indicating a robust momentum driven by AI and data center trades that are reshaping market dynamics.
- Storage Companies Benefit: Firms such as Seagate and Western Digital are favored by investors due to rising demand for memory and data infrastructure, further solidifying their market positions and reflecting a sustained preference for tech stocks.
- Defensive Stocks Under Pressure: Defensive consumer and healthcare stocks like Zoetis and Abbott are trading significantly below their long-term trends, illustrating a shift in investor preference towards high-beta tech stocks, resulting in severe overselling of these names.
- Cautious Sentiment in Software Sector: IT services and enterprise software companies, including Accenture and ServiceNow, feature prominently on the oversold list, indicating investor caution regarding the software trade amid slowing corporate spending and potential long-term disruptions from generative AI tools.
See More
Zoetis Under Investigation for Securities Fraud Claims
- Financial Performance Decline: Zoetis reported a net income of $601 million for Q1 2026, flat year-over-year, indicating the company is under pressure in a competitive market, which may affect future investor confidence.
- Guidance Downgrade: The company lowered its full-year 2026 earnings guidance to between $6.85 and $7.00 per share, down from $7.00 to $7.10, reflecting concerns over weakening market demand that could diminish shareholder confidence in the company's future performance.
- Significant Stock Drop: Following the earnings release on May 7, 2026, Zoetis's stock price plummeted by $23.91, or 21.5%, closing at $87.31, demonstrating a strong market reaction to the company's financial health, which may impact its ability to raise capital.
- Legal Investigation Initiated: Pomerantz LLP is investigating whether Zoetis and its executives engaged in securities fraud or other unlawful business practices, which could expose the company to legal risks and further impact its market reputation and shareholder value.
See More
Zoetis to Participate in Investor Conferences
- Investor Conference Schedule: Zoetis will participate in the Stifel 2026 Jaws & Paws Conference on May 28, 2026, at 3:00 p.m. ET, showcasing its latest advancements in animal health, which is expected to attract significant investor interest.
- Second Conference: Additionally, Zoetis will attend the William Blair 46th Annual Growth Stock Conference on June 2, 2026, at 1:20 p.m. CT, further enhancing the company's visibility and credibility among investors.
- Live Webcast Access: Interested investors can access live audio webcasts of the presentations by visiting the Zoetis investor website, which enhances interaction and transparency between the company and its investors.
- Company Background: Zoetis is the world's leading animal health company with nearly 75 years of history, dedicated to advancing animal care through innovation and scientific research, supporting veterinarians and livestock producers in over 100 countries.
See More
Zoetis Declares Quarterly Dividend of $0.53
- Quarterly Dividend Announcement: Zoetis has declared a quarterly dividend of $0.53 per share, consistent with previous distributions, indicating the company's stability amidst current market challenges despite declining sales.
- Dividend Yield: The forward yield of 2.66% provides investors with a relatively stable return, although the overall market sentiment regarding Zoetis's outlook remains cautious due to recent performance issues.
- Payment Schedule: The dividend will be payable on September 1, with a record date of July 20 and an ex-dividend date also set for July 20, ensuring shareholders receive their earnings promptly.
- Revenue Growth Forecast: Zoetis projects revenue growth of 2%-5% for 2026, reflecting a softening demand for U.S. companion animals, as the company continues to navigate market fluctuations and adapt its strategies accordingly.
See More
Michael Burry Doubles Down on Undervalued Stocks Amid AI Bubble Warning
- Market Bubble Warning: In his latest Substack post, Michael Burry cautions that the current AI boom resembles the final stages of the 1999 dot-com bubble, urging investors to exercise caution around momentum-driven trades and suggesting nearly complete reductions in positions for any stocks experiencing parabolic rises.
- Increased Holdings in Undervalued Stocks: Burry has added to his position in Latin American e-commerce giant MercadoLibre at around $1,500, describing it as a 'clean long-term winner' trading at a discount due to its international exposure, indicating a strategic focus on global markets.
- Diversified Investment Portfolio: In addition to MercadoLibre, Burry has boosted stakes in software maker Adobe, payments company PayPal, and animal health firm Zoetis, while establishing a full-sized position in athletic apparel retailer Lululemon, reflecting his confidence in traditional industries amidst the AI hype.
- Concentration of Risk: Burry highlights that 87% of venture capital funding is now directed toward AI-related companies, with nearly half of investment-grade bond issuance linked to AI, suggesting a concentration of capital that mirrors the dynamics preceding the 1999 internet bubble, indicating potential future risks.
See More
Earnings Season Volatility Hits US Stocks
- Strong Earnings Season: As the earnings season progresses, the S&P 500 reached an intraday record high of 7,501.24 on Thursday, reflecting strong investor confidence in corporate earnings, although it pulled back on Friday due to declines in tech stocks.
- Cisco's Stock Surge: Cisco shares soared 22% in one week following better-than-expected fiscal Q3 results, with a relative strength index (RSI) of 90 indicating the stock is in overbought territory, suggesting a potential short-term pullback risk.
- Zoetis Decline: Zoetis topped the oversold list with a 10% drop in the past week and an RSI of 14.4, as its Q1 earnings fell short of expectations and it lowered full-year EPS and revenue guidance, indicating pet owners are cutting back on vet visits due to price pressures.
- Market Sentiment Fluctuations: Despite strong performances from stocks like Cisco, the overall market experienced volatility due to disappointment over the U.S.-China summit outcomes, prompting investors to watch for potential rebounds in overbought and oversold stocks.
See More
Semiconductor Stocks Surge, Defensive Stocks Under Pressure
- Semiconductor Stocks Shine: Companies like Intel, Micron, and Seagate have surged over 40% in 2026, significantly exceeding their 200-day moving averages, indicating a robust momentum driven by AI and data center trades that are reshaping market dynamics.
- Storage Companies Benefit: Firms such as Seagate and Western Digital are favored by investors due to rising demand for memory and data infrastructure, further solidifying their market positions and reflecting a sustained preference for tech stocks.
- Defensive Stocks Under Pressure: Defensive consumer and healthcare stocks like Zoetis and Abbott are trading significantly below their long-term trends, illustrating a shift in investor preference towards high-beta tech stocks, resulting in severe overselling of these names.
- Cautious Sentiment in Software Sector: IT services and enterprise software companies, including Accenture and ServiceNow, feature prominently on the oversold list, indicating investor caution regarding the software trade amid slowing corporate spending and potential long-term disruptions from generative AI tools.
See More
